{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04057",
      "entity_text" : "miR-449a",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0460" ],
      "Organ" : [ "uberon:UBERON:2000106" ],
      "CellType" : [ "cl:CL:0002608" ]
    }
  },
  "verbose_text" : "To verify this hypothesis, the following experiments were conducted : A reverse transcription-quantitative polymerase chain reaction assay revealed that the expression level of miR-449a was significantly decreased in the prefrontal cortex and hippocampus of 12-month old SAMP8 mice; a dual-luciferase reporter assay verified that miR-449a regulated SCN2B expression by binding to the 3 '-UTR ' seed region '; an anti-Ago co-immunoprecipitation combined with Affymetrix micro-array analyses demonstrated that the target mRNA highly enriched with Ago-miRNPs was confirmed to be SCN2B.",
  "reading_complete" : "2020-08-03T17:39:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:39:05Z",
  "trigger" : "level",
  "evidence" : [ "level of miR-449a" ],
  "pmc_id" : "7053848",
  "score" : 0
}